Germany will overturn a decision not to offer the AstraZeneca-Oxford Covid-19 vaccine to over-65s, with Chancellor Angela Merkel saying recent studies showed it was effective in older age groups.
A handful of EU countries, including France and Germany, claimed there was limited evidence the shot protected older people.
"The [German] vaccine commission, whose recommendations we are happy to follow, will authorise AstraZeneca for older age groups," Mrs Merkel said.
Germany, which like most EU countries has been criticised for its slow vaccination campaign, has hundreds of thousands of AstraZeneca’s drug in storage, owing partly to public fears over its effectiveness.
-
A German worker tests a French national travelling into Germany at the German-French border near Saarbrucken. Germany announced Sunday that travelers from France's northeastern Moselle region will face additional restrictions. AP Photo -
A volunteer receives a dose of either the CureVac vaccine or a placebo, during a study by the German biotech firm CureVac as part of a testing for a new vaccine, in Brussels, Belgium. Reuters -
Commuters wearing face masks walk on a platform in the main train station in Frankfurt, Germany. AP Photo -
A German police staff member receives AstraZeneca's vaccine in Munich, Germany. Reuters -
An open clothes shop in Klazienaveen, The Netherlands. Shop owners have decided to open up their shops in a protest against the coronavirus measures. EPA -
An official puts warning tape around tables and chairs set up at a cafe in Alkmaar, The Netherlands. A group of 65 regional departments of Koninklijke Horeca Nederland (KHN) have called on catering entrepreneurs throughout the Netherlands to re-open their businesses in protest against restrictions. AFP -
Chief County Health Officer Tunde Szabo shows a box of Oxford/AstraZeneca vaccine at the freezing chamber of the Public Health Department in Nyiregyhaza, Hungary. AP Photo -
Soldiers with face masks prepare for the welcoming ceremony for Swiss President Guy Parmelin in Vienna, Austria. AP Photo -
A healthcare worker removes the stitches from a homeless man in a hotel in Prague, Czech Republic. Prague is using hotels to accommodate homeless people who tested positive for coronavirus. EPA -
A healthcare worker holds the hand of a homeless woman in a hotel in Prague, Czech Republic. EPA -
People stroll along the Sant'Angelo bridge in Rome, Italy. AP Photo
Only about 5 per cent of Germany's population have received at least one dose of the shot.
Belgium approved the AstraZeneca-Oxford vaccine on Wednesday and France will offer it to people aged between 65 and 74 with existing health conditions.
French President Emmanuel Macron described the shot as "quasi-ineffective" in January, but has since softened his views.
Like the UK, Germany decided on a 12-week gap between first and second doses to give more people protection against Covid-19.
Mrs Merkel set out how the country would loosen restrictions, although most will remain in place until March 28. But meeting up to five people from two other households will be permitted from Monday.
After meeting regional leaders, she said Germany was “at the threshold of a new phase of the pandemic” that the country would enter “with justified hope".
Meanwhile, the UK’s medical regulator said it would fast-track vaccines to protect against new strains of the virus, as concerns grow about variants such as those first reported in Brazil and South Africa that might be resistant to current inoculations.
The Medicines & Healthcare Products Regulatory Agency said the plan was based on the process used to protect people against flu every year, eliminating the need for time-consuming trials.
"Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety," said Christian Schneider, chief scientific officer at the agency.
"Should any modifications to authorised Covid-19 vaccines be necessary, this regulatory approach should help to do just that.”
The European Medicines Agency is looking into how it can speed up the approval process for vaccine adjustment.
“It appears that with continued mutations and new variants emerging, authorised vaccines may need to be adapted, in time to ensure continued protection," it said.
"Initial data indicates that some of these variants may have an impact on the level of protection provided by Covid-19 vaccines against infection and disease.
“Therefore, it is an urgent public health priority to define an expedited regulatory process for the adaptation of vaccines to protect against current or future variants.”
-
Britain's Prime Minister Boris Johnson joins Year 2 pupils in a maths lesson, during his visit to St Mary's C.E. Primary School in Stoke-on-Trent, central England. AFP -
Boris Johnson is visiting the school to see how their preparations are going ahead of students returning on March 8. AFP -
An aerial view of cars queuing at a temporary coronavirus testing centre in Stoke Gifford. Testing efforts were expanded in South Gloucestershire after three returning residents were recently found to have been infected with a Covid-19 variant first discovered in Brazil. Getty Images -
Patients wait in a post-vaccine observation area after receiving the AstraZeneca/Oxford University Covid-19 vaccine at the Darlington Arena Vaccination Centre. The vaccination centre in Darlington is the fourth large Vaccination Centre for the north east region. Getty Images -
Commuters alight from a tube train wearing face masks at Canning Town station in London. AP Photo -
Fiona Scott visits her mother Mary Cook at a nursing home for the first time since the lockdown started in Scotland. Reuters -
Commuters pass a Covid-19 advice board on London Bridge at sunrise. Getty Images -
People visit Primrose Hill in London. Reuters -
Doctor Anil Mehta, surrounded by his team of doctors, administers a dose of the Pfizer-BioNTech vaccine to Geeta Waddon to mark the 10,000th at his small practice in London. AP Photo -
Members of the public walk in a crowded Primrose Hill, London. Reuters -
Chester United under 13s players during a socially distance Zoom training session, in Ouston, north-east England. Reuters
